Bank Julius Baer & Co
ARNA

Bank Julius Baer & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bank Julius Baer & Co’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,979
Closed -$746K – 869
2020
Q3 		$746K Buy
9,979
+2,726
+38% +$182K 0.01% 331
2020
Q2 		$457K Buy
+7,253
New +$399K 0.01% 371

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank Julius Baer & Co's ARNA Position: Q4 2020 in Review

Bank Julius Baer & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 9,979 shares — an estimated $746K sold.

Bank Julius Baer & Co first reported a position in ARNA in Q2 2020 and held it in 2 quarters. The position peaked at $746K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Bank Julius Baer & Co reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Bank Julius Baer & Co sold 9,979 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $746K.
  • Bank Julius Baer & Co first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 2 quarters.
  • Bank Julius Baer & Co's Arena Pharmaceuticals Inc position peaked at $746K in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.